Goodwill in USD of Vitro Biopharma, Inc. from Q3 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Vitro Biopharma, Inc. quarterly Goodwill history and change rate from Q3 2022 to Q2 2025.
  • Vitro Biopharma, Inc. Goodwill for the quarter ending 31 Jul 2025 was $3.17M, a 12.1% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $3.17M -$437K -12.1% 31 Jul 2025 10-Q 12 Sep 2025
Q1 2025 $3.17M -$437K -12.1% 30 Apr 2025 10-Q 20 Jun 2025
Q4 2024 $3.17M -$437K -12.1% 31 Jan 2025 10-Q 20 Mar 2025
Q3 2024 $3.17M -$437K -12.1% 31 Oct 2024 10-Q 12 Sep 2025
Q2 2024 $3.61M $0 0% 31 Jul 2024 10-Q 16 Sep 2024
Q1 2024 $3.61M $0 0% 30 Apr 2024 10-Q 31 May 2024
Q4 2023 $3.61M $0 0% 31 Jan 2024 10-Q 14 Mar 2024
Q3 2023 $3.61M $0 0% 31 Oct 2023 10-K 28 Jan 2025
Q2 2023 $3.61M 31 Jul 2023 10-Q 28 Aug 2023
Q1 2023 $3.61M 30 Apr 2023 10-Q 13 Jun 2023
Q4 2022 $3.61M 31 Jan 2023 10-Q 14 Mar 2023
Q3 2022 $3.61M 31 Oct 2022 10-K 29 Jan 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.